Specific Granule Deficiency Due To Novel Homozygote SMARCD2 Variant
Pediatric Allergy, Immunology, and Pulmonology · 2022-03 · 35 (1) · 43-46
DOI: 10.1089/ped.2021.0070 ↗Kurz gefasst
Fallbericht in der Zeitschrift Pediatric Allergy, Immunology, and Pulmonology, online erschienen am 21.03.2022. Verfasst von Zeynep Kihtir und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neonatology, Akdeniz University Medical Faculty, Antalya, Turkey. Hauptthemen laut MEDLINE: Immunologic Deficiency Syndromes, Leukocyte Disorders. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 14 Literaturangaben.
Abstract (Originalsprache)
Background
Specific granule deficiency (SGD) is a rare immunodeficiency associated with CCAT/enhancer-binding protein epsilon (CEBPE) gene variants. It can cause severe recurrent infections and is lethal without successful stem cell transplantation. Few cases with SGD of both type 1 and type 2 have been described in the literature. In this study, we present the first report of a case with a novel homozygous c.511 C > T (p.Gln171Ter) mutation in the SMARCD2 gene of SGD type 2, which was successfully treated with bone marrow transplantation. Case: A male infant presented to our neonatal intensive care unit on the second day of life with an icteric appearance and mild hypotonia. He was evaluated for immunodeficiency as the cause of delayed cord separation and refractory neutropenia. At 6 weeks of age, SGD type 2 with a new variant was diagnosed and successfully treated by bone marrow transplantation.
Conclusion
SGD is an immunodeficiency disease that is quite rare. However, we believe that SGD diagnosis and associated new variants can be detected more frequently with the widespread use of all whole-exome sequencing techniques.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neonatology, Akdeniz University Medical Faculty, Antalya, Turkey.
- Department of Pediatric Hematology and Oncology, Akdeniz University Medical Faculty, Antalya, Turkey.
- Department of Pediatric Allergy and Immunology, Akdeniz University Medical Faculty, Antalya, Turkey.
- Intergen Genetic and Rare Diseases Diagnosis and Research Center, Ankara, Turkey.
ORCID-Profile: Zeynep Kihtir, Kıymet Çelik, Funda Tayfun Küpesiz, Osman Alphan Küpesiz, Dilara Fatma Kocacik Uygun, Sema Arayici, Hakan Ongun, İpek Acarbulut, Celal Sağlam, Gülay Ceylaner, Ayşen Bingöl
Zitieren
APA
Kihtir, Z., Çelik, K., Tayfun Küpesiz, F., Küpesiz, O. A., Kocacik Uygun, D. F., Arayici, S., Ongun, H., Acarbulut, İ., Sağlam, C., Ceylaner, G., & Bingöl, A. (2022). Specific Granule Deficiency Due To Novel Homozygote SMARCD2 Variant. Pediatric Allergy, Immunology, and Pulmonology, 35(1), 43-46. https://doi.org/10.1089/ped.2021.0070
Vancouver
Kihtir Z, Çelik K, Tayfun Küpesiz F, Küpesiz OA, Kocacik Uygun DF, Arayici S, et al. Specific Granule Deficiency Due To Novel Homozygote SMARCD2 Variant. Pediatric Allergy, Immunology, and Pulmonology. 2022;35(1):43-46. doi:10.1089/ped.2021.0070
BibTeX
@article{Kihtir2022,
author = {Kihtir, Zeynep and Çelik, Kıymet and Tayfun Küpesiz, Funda and Küpesiz, Osman Alphan and Kocacik Uygun, Dilara Fatma and Arayici, Sema and Ongun, Hakan and Acarbulut, İpek and Sağlam, Celal and Ceylaner, Gülay and Bingöl, Ayşen},
title = {Specific Granule Deficiency Due To Novel Homozygote SMARCD2 Variant},
journal = {Pediatric Allergy, Immunology, and Pulmonology},
year = {2022},
volume = {35},
number = {1},
pages = {43--46},
doi = {10.1089/ped.2021.0070}
}
EUVIMED